Status:

RECRUITING

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Lead Sponsor:

University of Aberdeen

Collaborating Sponsors:

NHS Tayside

NHS Lothian

Conditions:

Takotsubo Cardiomyopathy

Myocardial Infarction

Eligibility:

All Genders

Brief Summary

Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are unobstructed, it has been suggeste...

Detailed Description

Public Health Scotland will identify all patients centrally coded under codes I42.8 (Other cardiomyopathies), I42.9 (Cardiomyopathy, unspecified) and I51.8 (Other ill-defined heart diseases), using th...

Eligibility Criteria

Inclusion

  • All patients diagnosed with Takotsubo cardiomyopathy

Exclusion

  • NA

Key Trial Info

Start Date :

July 29 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT03299569

Start Date

July 29 2016

End Date

December 31 2028

Last Update

March 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cardiac Research Office

Aberdeen, Scotland, United Kingdom, AB25 2ZD

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland | DecenTrialz